Physician

Asfi Rafiuddin, D.O.

According to 2025 Medicare claims, Asfi Rafiuddin, D.O. (NPI: 1801200019) practices epileptologists in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is EPILEPSY & NEUROPHYSIOLOGY MEDICAL CONSULTANTS PA (NPI: 1013998830; TIN: 134015451) and primary practice location at 07601-1914. Rafiuddin is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Rafiuddin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 191 traditional Medicare patients, billed 551 HCPCS/CPT codes, and received $89,862 in Medicare payments. The top billing code was 95720 (Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional). Part D data shows 303 prescription claims across 39 beneficiaries totaling $221,379 in drug costs, led by Briviact (Brivaracetam). Open Payments data shows 47 records totaling $34,534. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,810 to $89,862. Similarly, Part D prescription costs have moved sharply higher in recent years, from $5,692 to $221,379. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	36	79	$11,810
2020	26	59	$6,042
2021	229	572	$74,674
2022	232	674	$86,767
2023	221	619	$94,196
2024	191	551	$89,862

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	35	81	$5,692
2016	16	36	$5,512
2017	14	48	$10,943
2018	12	45	$24,093
2019	27	109	$55,302
2020	26	68	$27,214
2021	45	113	$17,977
2022	47	210	$106,021
2023	38	159	$87,072
2024	39	303	$221,379

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95720	Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional	115	233	$173
95718	Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional	31	32	$112
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	16	22	$73
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	26	51	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	21	34	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Briviact	Brivaracetam	39	1,094	$72,261
Epidiolex	Cannabidiol (Cbd)	14	420	$70,735
Trokendi Xr	Topiramate	12	360	$31,422
Clobazam	Clobazam	24	720	$3,160
Lacosamide	Lacosamide	23	990	$1,840

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	45	$784	Neurelis, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$33,750	SK Life Science, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asfi Rafiuddin, D.O.?

Tedicare shows public-source Medicare data for Asfi Rafiuddin, D.O. (NPI 1801200019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asfi Rafiuddin, D.O. have ACO affiliation data?

Asfi Rafiuddin, D.O. is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Asfi Rafiuddin, D.O.?

Asfi Rafiuddin, D.O. is linked to EPILEPSY & NEUROPHYSIOLOGY MEDICAL CONSULTANTS PA (billing NPI 1013998830) in the available physician profile data.

Does Asfi Rafiuddin, D.O. have Open Payments data?

Asfi Rafiuddin, D.O. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.